LSB (LXU) shares surged 12.4% to $8.99 on robust volume, fueled by strong selling prices and favorable demand in the ammonia market, underpinned by tight supply fundamentals and higher-margin product sales. The chemical manufacturer projects Q1 earnings of $0.05 per share, a 145.5% year-over-year increase, on revenues of $119.32 million, up 9.3%. However, the consensus EPS estimate has remained unchanged over the last 30 days, which may temper expectations for sustained upward momentum despite the recent rally.
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. If you wish to go to ZacksTrade, click OK. If you do not, click Cancel. LSB (LXU) Surges 12.4%: Is This an Indication of Further Gains? Read MoreHide Full Article LSB (LXU - Free Report) shares ended the last trading session 12.4% higher at $8.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.4% loss over the past four weeks. Gains from strong selling prices and favorable demand have increased the company’s prospects, contributing to the price rally. Steady exports paired with lower imports have led to tight supply fundamentals. The ammonia market is benefiting as distribution channel inventories are balanced, the Middle-East supply remains disrupted and costs of production remain higher in Europe. Higher volumes of higher margin products and increased selling prices are driving the company’s top line. This chemical maker is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +145.5%. Revenues are expected to be $119.32 million, up 9.3% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For LSB, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on LXU going forward to see if this recent jump can turn into more strength down the road. LSB is a member of the Zacks Chemical - Diversified industry. One other stock in the same industry, DuPont de Nemours (DD - Free Report) , finished the last trading session 1.6% lower at $79.72. DD has returned 5% over the past month. For DuPont de Nemours, the consensus EPS estimate for the upcoming report has changed -0.2% over the past month to $1.13. This represents a change of -4.2% from what the company reported a year ago. DuPont de Nemours currently has a Zacks Rank of 3 (Hold). Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Image: Bigstock LSB (LXU) Surges 12.4%: Is This an Indication of Further Gains? LSB (LXU - Free Report) shares ended the last trading session 12.4% higher at $8.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.4% loss over the past four weeks. Gains from strong selling prices and favorable demand have increased the company’s prospects, contributing to the price rally. Steady exports paired with lower imports have led to tight supply fundamentals. The ammonia market is benefiting as distribution channel inventories are balanced, the Middle-East supply remains disrupted and costs of production remain higher in Europe. Higher volumes of higher margin products and increased selling prices are driving the company’s top line. This chemical maker is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +145.5%. Revenues are expected to be $119.32 million, up 9.3% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For LSB, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on LXU going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank 1 (Strong Buy) stocks here >>>> LSB is a member of the Zacks Chemical - Diversified industry. One other stock in the same industry, DuPont de Nemours (DD - Free Report) , finished the last trading session 1.6% lower at $79.72. DD has returned 5% over the past month. For DuPont de Nemours, the consensus EPS estimate for the upcoming report has changed -0.2% over the past month to $1.13. This represents a change of -4.2% from what the company reported a year ago. DuPont de Nemours currently has a Zacks Rank of 3 (Hold). Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up LSB Industries (LXU) experienced a significant 12.4% share price increase to $8.99, executed on higher-than-average trading volume, which notably reverses a 2.4% loss from the prior four weeks. The rally is fundamentally supported by strong selling prices and favorable demand dynamics within the ammonia market. These conditions are amplified by tight supply fundamentals, resulting from a combination of steady exports, reduced imports, supply disruptions in the Middle East, and elevated production costs in Europe. The company is projected to report a substantial 145.5% year-over-year increase in quarterly earnings to $0.05 per share on revenues of $119.32 million, up 9.3%. However, a critical counterpoint is that the consensus EPS estimate has remained unchanged over the last 30 days. This lack of upward analyst revisions suggests the recent price appreciation may not be supported by improving long-term sentiment, potentially limiting the rally's sustainability and indicating the move could be based on short-term market factors rather than a revised fundamental outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment
